Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Antihypertensive Drugs: Vasodilators

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sperm histone modifications may predict success in human assisted reproduction: a pilot study.

Journal of assisted reproduction and genetics·2024

Same author

Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice.

Neurologia·2024

Same author

Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism.

Revista clinica espanola·2024

Same author

Consensus on improving the comprehensive care of patients with acute heart failure.

Revista clinica espanola·2023

Same author

Efficacy and safety of high doses of safinamide in advanced Parkinson disease.

Parkinsonism & related disorders·2022

Same author

Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice.

Neurologia·2021

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Current pharmacological approach to restore endothelial dysfunction.

D Dobarro¹, M C Gómez-Rubín, A Sanchez-Recalde

¹Interventional Cardiology Unit, Planta 1a Diagonal, University Hospital La Paz, 28046 Madrid, Spain.

Cardiovascular & Hematological Agents in Medicinal Chemistry

|August 20, 2009

Summary

Endothelial dysfunction, an early sign of atherosclerosis, involves an imbalance in blood vessel tone. Restoring endothelial function may reverse disease progression and prevent cardiovascular events.

More Related Videos

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Related Experiment Videos

Last Updated: Jun 20, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Area of Science:

Cardiovascular Medicine
Vascular Biology
Pharmacology

Background:

Endothelial dysfunction impairs endothelium-dependent vasodilation, linked to risk factors like diabetes, hypertension, and smoking.
Severity correlates with coronary artery disease and cardiovascular events, suggesting it's an early stage of atherosclerosis.
Characterized by an imbalance between vasodilators (nitric oxide) and vasoconstrictors (endothelin-1).

Purpose of the Study:

To review current pharmacological management strategies for endothelial dysfunction.
To explore agents that improve vascular protection beyond their primary actions.

Main Methods:

Evaluation of invasive and non-invasive techniques for assessing endothelial function.
Analysis of pharmacological interventions targeting risk factors and novel mechanisms.

Main Results:

Restoration of endothelial function may regress atherosclerosis and prevent cardiovascular events.
Interventions target hypertension (ACE-inhibitors), dyslipidaemia (statins), and menopause (estrogens).
Agents like ACE-inhibitors, statins, nebivolol, BH4, and antioxidants offer vascular protection via diverse mechanisms.

Conclusions:

Endothelial dysfunction is a critical early marker in atherosclerosis.
Pharmacological interventions hold promise for improving endothelial function and cardiovascular outcomes.
Further research into novel mechanisms of vascular protection is warranted.